Aranesp

DRUG6 trials

Sponsors

Amgen, University of Washington, Dong-A ST Co., Ltd., Biocad

Conditions

AnemiaBreast CancerChronic Kidney Disease, Receiving DialysisHealthyProstate CancerSymptomatic Anemia

Phase 1

A Study in Healthy Volunteers to Compare the Profiles of DA-3880 and EU Sourced ARANESP® (Amgen)

CompletedNCT02241200

Dong-A ST Co., Ltd.Symptomatic Anemia

Start: 2014-08-18End: 2014-11-29Updated: 2021-06-15

The Study of PK, PD, Safety of Multiple Intravenous Injections of BCD-066 and Aranesp in Healthy Volunteers

CompletedNCT03693950

Start: 2017-03-28End: 2017-07-03Updated: 2020-04-21

Phase 2

Study of Aranesp to Treat Anemia in Prostate Cancer Patients.

CompletedNCT00245895

University of WashingtonAnemia, Prostate Cancer

Start: 2003-04-30End: 2005-02-28Updated: 2007-11-29

ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer

CompletedNCT00261313

AmgenBreast Cancer

Start: 2005-12-31End: 2007-12-31Updated: 2010-02-26

Phase 4

A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®

CompletedNCT00117117

Start: 2002-09-30End: 2003-12-31Target: 2423Updated: 2009-03-25

Unknown Phase

Study of South African Dialysis Patients

TerminatedNCT01890577

AmgenChronic Kidney Disease, Receiving Dialysis

Start: 2013-04-30End: 2014-01-31Updated: 2016-07-12